Thousands in the UK sue Johnson & Johnson over asbestos-linked talc. The £1 billion lawsuit could award victims up to ...

There’s a dark underbelly to popular cosmetic treatments which are causing torturous and agonising experiences for some ...

Dr. Polo, I stay in great shape and work hard at core strengthening but I just can’t get the definition in my abs that I have ...

From invasive weeds that can cause structural damage and cost thousands to irradicate, to pretty blooms harboring poison ...

About half of women over 40 have dense breasts. The denser the breast tissue, the more difficult it is to spot cancer on a ...

The approval is the first in more than a decade for an idiopathic pulmonary fibrosis treatment. The FDA has approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of adults with ...

Jascayd is the first new IPF therapy approved in over 10 years, addressing a rare and serious disease with limited treatments. FDA approval was based on Phase III trials showing reduced FVC decline ...

Gene editing, led by CRISPR, is expanding rapidly beyond medical applications, offering new opportunities across various biotech industries. Technological breakthroughs are fueling acceleration and ...

Credit: Boehringer Ingelheim. Nerandomilast reduces the expression of pro-fibrotic growth factors and inflammatory cytokines, commonly overexpressed in IPF. Findings showed nerandomilast led to a ...